WallStreetZenWallStreetZen

NASDAQ: MURA
Mural Oncology PLC Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for MURA

Based on 1 analyst offering 12 month price targets for Mural Oncology PLC.
Min Forecast
$13.00+263.13%
Avg Forecast
$13.00+263.13%
Max Forecast
$13.00+263.13%

Should I buy or sell MURA stock?

Based on 1 analyst offering ratings for Mural Oncology PLC.
Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their MURA stock forecasts and price targets.

MURA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-04

1 of 1

Forecast return on equity

Is MURA forecast to generate an efficient return?

Forecast return on assets

Is MURA forecast to generate an efficient return on assets?

MURA revenue forecast

What is MURA's revenue in the next 1 years based on estimates from 1 analyst?
Avg 1 year Forecast
$26.1M

MURA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
MURA$3.58$13.00+263.13%Strong Buy
EQ$1.71$5.00+192.40%Buy
KRON$1.00$4.25+325.00%Strong Buy
THTX$1.30N/AN/A
ALGS$0.78N/AN/A
View Top Biotech Stocks

Mural Oncology Stock Forecast FAQ

Is Mural Oncology Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: MURA) stock is to Strong Buy MURA stock.

Out of 1 analyst, 1 (100%) are recommending MURA as a Strong Buy, 0 (0%) are recommending MURA as a Buy, 0 (0%) are recommending MURA as a Hold, 0 (0%) are recommending MURA as a Sell, and 0 (0%) are recommending MURA as a Strong Sell.

If you're new to stock investing, here's how to buy Mural Oncology stock.

What is MURA's revenue growth forecast for 2026-2026?

(NASDAQ: MURA) Mural Oncology's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 61.02%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.08%.

Mural Oncology's revenue in 2024 is $0.

In 2026, MURA is forecast to generate $441,001,653 in revenue, with the lowest revenue forecast at $441,001,653 and the highest revenue forecast at $441,001,653.

What is MURA's forecast return on assets (ROA) for 2026-2026?

(NASDAQ: MURA) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 8.04%.

What is MURA's Price Target?

According to 1 Wall Street analyst that have issued a 1 year MURA price target, the average MURA price target is $13.00, with the highest MURA stock price forecast at $13.00 and the lowest MURA stock price forecast at $13.00.

The Wall Street analyst predicted that Mural Oncology's share price could reach $13.00 by Apr 4, 2025. The average Mural Oncology stock price prediction forecasts a potential upside of 263.13% from the current MURA share price of $3.58.

What is MURA's forecast return on equity (ROE) for 2026-2026?

(NASDAQ: MURA) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.